Search research articles
Contact Us
Filters
Showing results (331-340 of 357) with videos related to
Page
of 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression
Julian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.
European Urology Focus
|
July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Scientific Reports
|
November 10, 2020
Evaluation of pathogen specific urinary peptides in tick-borne illnesses
Ruben Magni, Raghad Almofee, Sameen Yusuf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2017
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Robert J Motzer, Naomi B Haas, Frede Donskov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial
Robert J Motzer, Axel Bex, Paul Russo, et al.
Nature Communications
|
October 8, 2016
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
Ying-Bei Chen, Jianing Xu, Anders Jacobsen Skanderup, et al.
European Urology
|
November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
Mark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
European Urology Oncology
|
October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
Hong Truong, Rania Sheikh, Ritesh Kotecha, et al.
JCI Insight
|
June 15, 2017
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli, Nils Weinhold, Gunes Gundem, et al.
Genome Medicine
|
December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
Mahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 357) with videos related to
Sort By:
Page
of 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression
Julian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.
European Urology Focus
|
July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Scientific Reports
|
November 10, 2020
Evaluation of pathogen specific urinary peptides in tick-borne illnesses
Ruben Magni, Raghad Almofee, Sameen Yusuf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2017
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
Robert J Motzer, Naomi B Haas, Frede Donskov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial
Robert J Motzer, Axel Bex, Paul Russo, et al.
Nature Communications
|
October 8, 2016
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
Ying-Bei Chen, Jianing Xu, Anders Jacobsen Skanderup, et al.
European Urology
|
November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
Mark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
European Urology Oncology
|
October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
Hong Truong, Rania Sheikh, Ritesh Kotecha, et al.
JCI Insight
|
June 15, 2017
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Jozefina Casuscelli, Nils Weinhold, Gunes Gundem, et al.
Genome Medicine
|
December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
Mahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Page
of 36